GE Healthcare Announces $1.5 Billion Notes Offering

GE Healthcare Technologies Inc ( (GEHC) ) has provided an announcement.

On June 3, 2025, GE Healthcare Technologies Inc. announced the commencement and pricing of an underwritten offering of $1.5 billion in aggregate principal amount of notes. This offering, which includes $650 million of 4.800% Notes due in 2031 and $850 million of 5.500% Notes due in 2035, is expected to be issued around June 9, 2025, and aims to strengthen the company’s financial position. The offering is managed by major financial institutions including Citigroup, J.P. Morgan, and Morgan Stanley, indicating a strong market interest and confidence in GE Healthcare’s financial strategies.

The most recent analyst rating on (GEHC) stock is a Buy with a $100.00 price target. To see the full list of analyst forecasts on GE Healthcare Technologies Inc stock, see the GEHC Stock Forecast page.

Spark’s Take on GEHC Stock

According to Spark, TipRanks’ AI Analyst, GEHC is a Outperform.

GE Healthcare Technologies Inc has a solid overall stock score driven by strong financial performance and reasonable valuation. However, recent earnings call insights reveal significant challenges due to tariffs and market issues in China, impacting future profit and cash flow expectations. Technical analysis indicates a neutral trend, reflecting uncertainty in market sentiment.

To see Spark’s full report on GEHC stock, click here.

More about GE Healthcare Technologies Inc

GE Healthcare Technologies Inc. operates in the healthcare industry, focusing on providing medical technologies and digital solutions. The company is known for its advanced imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, catering to healthcare providers and researchers globally.

Average Trading Volume: 4,978,845

Technical Sentiment Signal: Strong Sell

Current Market Cap: $32.12B

For a thorough assessment of GEHC stock, go to TipRanks’ Stock Analysis page.